Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) Meeting Abstract


Authors: Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; Sugarman, S. M.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Patil, S.; Covey, A.; Berger, M.; Lacouture, M.; Norton, L.; Hudis, C. A.; Baselga, J.; Chandarlapaty, S.; Dickler, M.
Abstract Title: Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
Meeting Title: 106th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 75
Issue: 15 Suppl.
Meeting Dates: 2015 Apr 18-22
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-08-01
Language: English
ACCESSION: WOS:000371597100101
DOI: 10.1158/1538-7445.am2015-ct330
PROVIDER: wos
Notes: Meeting Abstract: CT330 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Sujata Patil
    481 Patil
  2. Mario E Lacouture
    354 Lacouture
  3. Mary Ellen Moynahan
    105 Moynahan
  4. Clifford Hudis
    899 Hudis
  5. Larry Norton
    689 Norton
  6. Chau Dang
    214 Dang
  7. Diana E Lake
    79 Lake
  8. Maura N Dickler
    261 Dickler
  9. Anne Covey
    145 Covey
  10. Elizabeth Comen
    61 Comen
  11. Tiffany A Traina
    201 Traina
  12. Shanu Modi
    191 Modi
  13. Shari Goldfarb
    119 Goldfarb
  14. Michael Forman Berger
    560 Berger
  15. Payal Deepak Shah
    16 Shah
  16. Jose T Baselga
    480 Baselga
  17. Stephen James Zamora
    8 Zamora
Related MSK Work